睡眠限制联合刺激控制治疗原发性失眠的临床观察

Clinical Observation of Sleep Restriction Combined with Stimulation Control in Treatment of Primary Insomnia

目的:观察睡眠限制联合刺激控制对原发性失眠(primary insomnia,PI)患者睡眠状况及催眠药物剂量的影响。方法:选取2018年7月-2019年5月笔者所在医院睡眠医学科收治的60例PI患者为观察对象,经抽签法平均分为观察组和对照组,对照组接受睡眠卫生教育+口服唑吡坦片治疗,观察组在对照组基础上配合睡眠限制联合刺激控制,记录两组治疗前后PSQI得分及治疗后唑吡坦片减药量。结果:治疗前两组PSQI评分比较差异无统计学意义(P>0.05),治疗后观察组各维度评分及总分均低于对照组,差异均有统计学意义(P<0.05)。观察组唑吡坦片减药量高于对照组,差异有统计学意义(P<0.05)。结论:睡眠限制联合刺激控制对PI患者的睡眠状况有积极的影响,可以有效减少催眠药物剂量,给PI患者带来更佳的临床疗效,为PI的治疗提供高效易行的临床治疗方法。

Objective:To observe the effects of sleep restriction combined with stimulation control on sleep state and dose of hypnotics in PI patients.Method:A total of 60 PI patients admitted to the Department of Sleep Medicine of the author's hospital from July 2018 to May 2019 were selected as observation subjects,they were evenly divided into the observation group and the control group by lottery.The control group received sleep hygiene education and oral Zolpidem Tablets treatment.The observation group was combined with sleep restriction and stimulation control on the basis of the control group.PSQI scores before and after treatment and reduced dosage of Zolpidem Tablets after treatment were recorded in the two groups.Result:There were no statistically significant differences in PSQI scores between the two groups before treatment(P>0.05),after treatment,all dimension scores and total scores in the observation group were lower than those in the control group,the differences were statistically significant(P<0.05).The reduced dosage of Zolpidem Tablets in the observation group was higher than that in the control group,the difference was statistically significant(P<0.05).Conclusion:Sleep restriction combined with stimulation control has a positive effect on the sleep status of PI patients,which can effectively reduce the dose of hypnotic drugs,bring better clinical efficacy to PI patients,and provide efficient and feasible clinical treatment methods for the treatment of PI.